• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-yung Loo, Chi-Kei Lam, Masakazu Toi
  • Medicine
  • The Journal of Steroid Biochemistry and Molecular…
  • 2008 (First Published: 1 July 2008)
  • OBJECTIVES To evaluate the efficacy and safety of combing aromatase inhibitor (AI) and cyclooxygenase-2 (COX-2) inhibitor neoadjuvantly in postmenopausal patients with invasive hormone-sensitiveContinue Reading
  • Adrian Yun-San Yip, Wings Tjing-yung Loo, Louis W.C. Chow
  • Medicine
  • Biomedicine & pharmacotherapy = Biomedecine…
  • 2007 (First Published: 1 October 2007)
  • BACKGROUND Hepatitis B virus (HBV) infection afflicts Asia population and, in Hong Kong, about 10% was Hepatitis B surface antigen carrier. It is still one of the major issues under investigation.Continue Reading
  • Louis W.C. Chow, Stewart Yuk Tung, +5 authors Stefan Glück
  • Medicine
  • Expert opinion on investigational drugs
  • 2013 (First Published: 1 March 2013)
  • OBJECTIVES This prospective study aimed at investigating the efficacy and safety of the concurrent use of celecoxib (CXB) with 5-fluorouracil, epirubicin and cyclophosphamide (FEC), followed byContinue Reading
  • Louis W.C. Chow, Adrian Yun-San Yip, Romy Hing-Kwan Chan, Masakazu Toi
  • Medicine
  • 2010 (First Published: 20 May 2010)
  • e11073 Background: Anthracycline and taxane have been widely used and studied in neoadjuvant setting for treatment of locally advanced breast cancer. Although addition of COX-2 inhibitors mightContinue Reading
  • Louis Wing-Cheong Chow, Adrian Yun-San Yip, W. P. Chu, Wings Tjing-yung Loo, Masakazu Toi
  • Medicine
  • The Journal of Steroid Biochemistry and Molecular…
  • 2011 (First Published: 1 May 2011)
  • OBJECTIVE Anti-aromatase therapy is important in the treatment of breast cancer in postmenopausal women but they have effects on the bone mineral density (BMD) and osteoporosis. Cyclooxygenase-2Continue Reading